General informationNotification NumberB/FR/06/01/06Member State to which the notification was sentFranceDate of acknowledgement from the Member State Competent Authority12/12/2005Title of the ProjectApplication for the deliberate release of genetically modified NK603 (MON-ØØ6Ø3-6) maizeProposed period of release:01/04/2006 to 31/12/2009Name of the Institute(s) or Company(ies)Pioneer Genetique, Chemin de l'Enseigure
3. Is the same GMPt release planned elsewhere in the Community?NoHas the same GMPt been notified elsewhere by the same notifier?NoGenetically modified plantComplete name of the recipient or parental plant(s)
2. Description of the traits and characteristics which have been introduced or modified, including marker genes and previous modifications:NK603 maize has been genetically modified to tolerate application of glyphosate herbicide, which allows the farmers to use a broad-spectrum, non-selective, systemic herbicide for the weeding of the maize fields.Genetic modification3. Type of genetic modification:Insertion; In case of insertion of genetic material, give the source and intended function of each constituent fragment of the region to be inserted:NK603 maize, from Monsanto, has been genetically modified by the introduction of the cp4epsps gene, from Agrobacterium sp. strain CP4, that confers tolerance to glyphosate herbicide, along with the regulatory components necessary for expression in maize plant:
|Common Name||Family Name||Genus||Species||Subspecies||Cultivar/breeding line|
|maize||poaceae||zea||zea mays||mays||experimental varieties|
- the cp4epsps gene, the P-ract1/ract1 intron + ctp2, the NOS 3’ terminator.
- the cp4epsps gene, the CaMV e35S promoter + Zmhsp70 + ctp2, the NOS 3’ terminator.6. Brief description of the method used for the genetic modification:The genetic modification was done using particle acceleration method by Monsanto. Subsequently, maize plants tested in the trials have been obtained by traditional breeding.7. If the recipient or parental plant is a forest tree species, describe ways and extent of dissemination and specific factors affecting dissemination:Not applicable.Experimental Release1. Purpose of the release:The purpose of the release is to collect additional data on NK603 maize varieties. Studies will be carried out to observe the plant behavior, the herbicide application effects and the expression of the genes introduced in comparison with genetically modified maize combinations containing NK603 maize.2. Geographical location of the site:The releases are planned at several locations in France within the following areas: Nord-Pas-de-Calais (Nord), Picardie (Aisne, Oise, Somme), Bourgogne (Saône et Loire), Rhône-Alpes (Ain, Isère, Drome), Centre (Eure et Loir, Loir et Cher, Indre, Indre et Loire, Loiret), Aquitaine (Landes, Lot et Garonne), Midi-Pyrénées (Haute-Garonne, Gers, Tarn, Tarn et Garonne), Languedoc-Roussillon (Aude).3. Size of the site (m2):Every year, there could have up to 12 sites of release, each sown with up to 5000 m² of genetically modified NK603 maize subject of this notification. Other genetically modified maize may be planted on the same sites of release. Thus, the total trial surface for each site (all varieties and borders included) will be larger.4. Relevant data regarding previous releases carried out with the same GM-plant, if any, specifically related to the potential environmental and human health impacts from the release:Field trials have already been conducted in several locations with this genetically modified maize and no environmental problems were reported for these trials. The transgenic plants have appeared normal in all respects. They were indistinguishable from the non-genetically modified maize plants, except for showing herbicide tolerance when glyphosate is applied, trait due to the genetic modification.Environmental Impact and Risk ManagementSummary of the potential environmental impact from the release of the GMPts:No risks to human and animal health or to the environment from the deliberate release of genetically modified maize tolerant to glyphosate are expected, as per information contained in Summary Notification Information Format of notification C/ES/03/01.Brief description of any measures taken for the management of risks:The shedding of pollen from the genetically modified plants will be controlled by maintaining a 200-meter isolation distance with any other non-experimental maize crop. In addition, the trial will be surrounded by four border rows of conventional maize of a similar relative maturity that will be also destroyed at the end of the release.
Seed dispersal of individual kernels does not generally occur. They are fixed on a cob and enclosed in many husks that protect the seeds from outside contact. When a few seeds need to be collected for analysis; this will be done by sampling the whole ear and unused seeds will be destroyed.
In case of any emergency, the trial could be stopped by application of a non-selective herbicide other than glyphosate or by mechanical destruction and incorporation into the soil.
At the end of the release, all remaining plant matter that has not been harvested for analyses will be destroyed by chopping and incorporating into the soil. No plant or plant product coming from the trials will enter the food or feed chains.
Volunteer maize will be monitored during the following year. An herbicide treatment (other than glyphosate) will be used in order to ensure destruction if needed.
No commercial maize will be cultivated in the trial site the following year.Summary of foreseen field trial studies focused to gain new data on environmental and human health impact from the release:Not applicable to this release.Final report-European Commission administrative informationConsent given by the Member State Competent Authority:Yes19/05/2006 00:00:00Remarks: